Animalytix® delivers valuable information, insight, and analysis of the animal health industry via 3 principal service offerings:
A subscription information service, Animalytix® provides timely and detailed reporting on the sales of veterinary pharmaceuticals, vaccines, insecticides, and other animal health products sold for the following market segments:
Ruminants - Currently Available
Anti-Infectives: Premium Injectables (ALYX-5.1)
Anti-Infectives: Traditional Injectables and Boluses (ALYX-5.2)
Anti-Infectives: Intramammary Infusion (ALYX-5.3)
Anti-Infectives: Soluble Powders and Solutions (ALYX-5.4)
Anti-Parasitics: Endos & Endectocides (ALYX-6.1)
Anti-Parasitics: Premise & Ectoparasiticides (ALYX-6.2)
Productivity Enhancers (ALYX-7)
Reproductive Hormones (ALYX-8)
Specialty Pharmaceuticals (ALYX-9)
Vaccines (ALYX-10)
Equine - Currently Available
Pharmaceuticals (ALYX-13)
Vaccines (ALYX-14)
Specialty Pharmaceuticals (ALYX-18)
Dermatologicals (ALYX-20)
Nutraceuticals (ALYX-21)
Human Labeled Pharmaceuticals (ALYX-22)
Swine (available Q3 2012)
Pharmaceuticals (ALYX-11)
Vaccines (ALYX-12)
The ALYX Market Survey Series is published monthly and delivered electronically to subscribers via a secure web portal. For further information regarding report availability, subscription fees, and additional services, click here.
Only Animalytix® delivers a data platform with sufficient statistical robustness to allow its use without further extrapolations, enrichments, or other manipulations. Only the ALYX Market Survey provides data and analytics capabilities sufficient to support tactical and strategic business decision making in a near-real-time operating environment.